Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOLFOXIRI Regimen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06733038
What this trial is testing

FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 238
Testing effectiveness (Phase 2)UnknownNCT05353582
What this trial is testing

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

Who this might be right for
Colorectal NeoplasmsColorectal CancerColorectal Cancer Metastatic+6 more
Sun Yat-sen University 168
Testing effectiveness (Phase 2)WithdrawnNCT01540435
What this trial is testing

Perioperative Treatment of Resectable Liver Metastases

Who this might be right for
Colon Cancer Liver Metastasis
University of Regensburg
Testing effectiveness (Phase 2)UnknownNCT04034459
What this trial is testing

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC

Who this might be right for
Metastatic Colorectal Cancer
Ludwig-Maximilians - University of Munich 109
Testing effectiveness (Phase 2)Study completedNCT00940303
What this trial is testing

OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 97
Large-scale testing (Phase 3)UnknownNCT04338191
What this trial is testing

MFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 638
Large-scale testing (Phase 3)UnknownNCT02339116
What this trial is testing

Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 654
Large-scale testing (Phase 3)Not Yet RecruitingNCT07472868
What this trial is testing

Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Carcinoma
J. W. A. Burger 394
Large-scale testing (Phase 3)Study completedNCT00719797
What this trial is testing

Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 509
Not applicableUnknownNCT04852250
What this trial is testing

Centralized Tumour Board and Secondary Intervention Rate in mCRC

Who this might be right for
Metastatic Colorectal CancerRAS MutationMultidisciplinary Communication+1 more
Ludwig-Maximilians - University of Munich 130
Testing effectiveness (Phase 2)Study completedNCT02351219
What this trial is testing

FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Stage III
Azienda Ospedaliero, Universitaria Pisana 50
Testing effectiveness (Phase 2)Study completedNCT04380337
What this trial is testing

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

Who this might be right for
Rectal Cancer
Stanford University 38
Testing effectiveness (Phase 2)UnknownNCT01802645
What this trial is testing

Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
Technische Universität Dresden 91
Testing effectiveness (Phase 2)WithdrawnNCT03161574
What this trial is testing

FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer

Who this might be right for
Rectal Cancer
Guangxi Medical University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03997435
What this trial is testing

FOLFOXIRI With or Without Intensification for Rectal Cancer

Who this might be right for
Rectal Cancer
CCTU 72
Testing effectiveness (Phase 2)UnknownNCT02942563
What this trial is testing

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
RenJi Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT01126866
What this trial is testing

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

Who this might be right for
Colorectal Carcinoma
National Center for Tumor Diseases, Heidelberg 35
Testing effectiveness (Phase 2)UnknownNCT03484221
What this trial is testing

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal NeoplasmsDrug TherapyRadiation
China Medical University, China 30
Testing effectiveness (Phase 2)UnknownNCT02515734
What this trial is testing

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab

Who this might be right for
Colorectal Cancer
Japan Clinical Cancer Research Organization 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT01941641
What this trial is testing

Colon Neoadjuvant FOLFOXIRI Study

Who this might be right for
Rectal Cancer
Chinese University of Hong Kong 40
Next Page